Literature DB >> 21591821

Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals.

E S Sunila1, T P Hamsa, Girija Kuttan.   

Abstract

CONTEXT: Tumor microenvironment induces an active immune tolerance and escapes immune surveillance. In order to achieve an effective antitumor immune response, appropriately activated immune cells should maintain their antitumor activity to overcome the immune suppressive tumor microenvironment.
OBJECTIVES: This study focuses on the effect of Thuja occidentalis L. (Cupressaceae) extract and its polysaccharide (TPS) on cell-mediated immune response (CMI) in metastasis bearing mice.
MATERIALS AND METHODS: Metastasis was induced by injecting B16F-10 melanoma cells in mice through the tail vein and effector mechanisms of CMI was studied by analyzing cytotoxic T-lymphocyte (CTL) activity, natural killer (NK) cell activity, antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent complement-mediated cytotoxicity (ACC). The effect of T. occidentalis and TPS on pro-inflammatory cytokines and tissue inhibitor matrix metalloproteinases (TIMP) levels were also analyzed. RESULTS AND DISCUSSION: Administration of T. occidentalis and TPS enhanced the NK cell activity, ADCC and ACC much earlier than the control tumor-bearing animals. T. occidentalis and TPS were also found to decrease the elevated level of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, GM-CSF and tumor necrosis factor (TNF)-α in the serum of metastatic tumor-bearing animals. The level of antitumor factors such as IL-2 and TIMP was elevated by the treatment with T. occidentalis and TPS in the serum, which was lowered in the untreated tumor-bearing animals.
CONCLUSION: This study clearly suggests that T. occidentalis and TPS effectively stimulate cell-mediated immune system and decrease pro-inflammatory cytokines, thereby inhibiting metastasis of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21591821     DOI: 10.3109/13880209.2011.565351

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

1.  Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells.

Authors:  Angelo Torres; Yosselyn Vargas; Daniel Uribe; Cristian Carrasco; Cristian Torres; René Rocha; Carlos Oyarzún; Rody San Martín; Claudia Quezada
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

2.  Amelioration of Scopolamine-Induced Learning and Memory Impairment by α-Pinene in C57BL/6 Mice.

Authors:  Gil-Yong Lee; Chan Lee; Gyu Hwan Park; Jung-Hee Jang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-01       Impact factor: 2.629

3.  Effects of a natural multi-component compound formulation on the growth, morphology and extracellular matrix production of human adult dermal fibroblasts.

Authors:  Monica Benvenuto; Rosanna Mattera; Martino Tony Miele; Maria Gabriella Giganti; Ilaria Tresoldi; Loredana Albonici; Vittorio Manzari; Andrea Modesti; Laura Masuelli; Roberto Bei
Journal:  Exp Ther Med       Date:  2019-08-08       Impact factor: 2.447

Review 4.  Thuja occidentalis L. (Cupressaceae): Ethnobotany, Phytochemistry and Biological Activity.

Authors:  Sonia Caruntu; Alina Ciceu; Neli Kinga Olah; Ioan Don; Anca Hermenean; Coralia Cotoraci
Journal:  Molecules       Date:  2020-11-19       Impact factor: 4.411

5.  Photodynamic Effects of Thuja occidentalis on Lung Cancer Cells.

Authors:  Ayesha Loonat; Rahul Chandran; Janice Pellow; Heidi Abrahamse
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

6.  A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.

Authors:  Iris R Bell; Mary Koithan
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

Review 7.  Natural products and their derivatives: Promising modulators of tumor immunotherapy.

Authors:  Li-Juan Deng; Ming Qi; Nan Li; Yu-He Lei; Dong-Mei Zhang; Jia-Xu Chen
Journal:  J Leukoc Biol       Date:  2020-07-17       Impact factor: 4.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.